title: HIV protease inhibitors, the lipodystrophy syndrome and polycystic ovary syndrome--is there a link?
authors.affiliation: Department of Genitourinary Medicine, General Infirmary at Leeds.
authors.forename: J D
authors.initials: JD
authors.lastname: Wilson
authors.forename: R J
authors.initials: RJ
authors.lastname: Dunham
authors.forename: A H
authors.initials: AH
authors.lastname: Balen
mesh_terms: D000328:Adult; D005260:Female; D020022:Genetic Predisposition to Disease; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007333:Insulin Resistance; D008060:Lipodystrophy / Q000139:chemically induced* / Q000235:genetics; D011085:Polycystic Ovary Syndrome / Q000139:chemically induced* / Q000235:genetics
chemical_list: D017320:HIV Protease Inhibitors